Gerresheimer AG (GRRMF)
32.20
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Gerresheimer EPS Diluted (Quarterly) : -10.34 for Nov. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| November 30, 2025 | -10.34 |
| August 31, 2025 | -0.4269 |
| May 31, 2025 | 0.5473 |
| February 28, 2025 | -0.5433 |
| November 30, 2024 | 1.167 |
| August 31, 2024 | 0.8569 |
| May 31, 2024 | 1.015 |
| February 29, 2024 | 0.4092 |
| November 30, 2023 | 1.287 |
| August 31, 2023 | 0.887 |
| May 31, 2023 | 1.136 |
| February 28, 2023 | 0.4101 |
| November 30, 2022 | 1.045 |
| August 31, 2022 | 0.8958 |
| May 31, 2022 | 0.8654 |
| February 28, 2022 | 0.387 |
| November 30, 2021 | 1.009 |
| August 31, 2021 | 0.7237 |
| May 31, 2021 | 1.075 |
| February 28, 2021 | 0.3558 |
| November 30, 2020 | 1.128 |
| August 31, 2020 | 0.931 |
| May 31, 2020 | 1.010 |
| February 29, 2020 | 0.1455 |
| November 30, 2019 | -2.924 |
| Date | Value |
|---|---|
| August 31, 2019 | 0.6591 |
| May 31, 2019 | 1.666 |
| February 28, 2019 | 3.585 |
| November 30, 2018 | 1.579 |
| August 31, 2018 | 0.6826 |
| May 31, 2018 | 0.7272 |
| February 28, 2018 | 1.879 |
| November 30, 2017 | 1.416 |
| August 31, 2017 | 0.9448 |
| May 31, 2017 | 0.8444 |
| February 28, 2017 | 0.4349 |
| November 30, 2016 | 1.584 |
| August 31, 2016 | 1.106 |
| May 31, 2016 | 1.059 |
| February 29, 2016 | 0.5686 |
| November 30, 2015 | 1.924 |
| August 31, 2015 | 0.6446 |
| May 31, 2015 | 0.71 |
| February 28, 2015 | 0.4117 |
| November 30, 2014 | 0.7993 |
| August 31, 2014 | 0.782 |
| May 31, 2014 | 0.8412 |
| February 28, 2014 | 0.3962 |
| November 30, 2013 | 1.066 |
| August 31, 2013 | 0.7518 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sartorius AG | 0.2219 |
| SCHOTT Pharma AG & Co. KGaA | 0.0749 |
| Agilent Technologies, Inc. | 1.198 |
| Bio-Rad Laboratories, Inc. | 13.85 |
| Bruker Corp. | -0.413 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -357.13M |
| Revenue (Quarterly) | 744.91M |
| Total Expenses (Quarterly) | 1.102B |
| Enterprise Value | 3.463B |
| Gross Profit Margin (Quarterly) | 0.28% |
| Profit Margin (Quarterly) | -47.94% |
| Earnings Yield | -33.43% |
| Normalized Earnings Yield | -15.29 |